title: Treatment for malignant struma ovarii in the eyes of thyroid surgeons: a case report and study of Chinese cases reported in the literature.
abstract: Malignant struma ovarii (MSO) is a rare malignant ovarian germ cell tumor that has been scarcely reported by thyroid surgeons focusing on treatment. There are no golden standards for its treatment. There has not been any Chinese case included in the English language literatures. This is the first study by collecting all Chinese cases with clinical information. We emphasize on using I therapy after operation.Presented is a case of struma ovarii with malignant histologic features who underwent definitive initial surgery of reproductive system tumors and a total thyroidectomy combined with thyroid-stimulating hormone (TSH)-suppressive therapy following treatment with I. Furthermore, a Chinese full-text database literature search for cases of MSO was performed, and advisable clinical data were collected following our treatment advice.Clinical data from 34 additional cases were compiled. As Chinese genetic background and environment are different from those of Western countries, our clinical data closely mirror theirs in some aspects. In addition, we provide a rare gene mutation type of MSO by the case from our department.Integrating literatures with the experience of thyroid surgeons, we recommend "multidisciplinary joint treatment" for MSO, namely traditional radical initial surgery of ovarian cancer and a total thyroidectomy combined with TSH-suppressive therapy following treatment with I for those who do not desire preservation of fertility.
authors.affiliation: From the Emergency Center (J-RL), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital; Department of Clinical Laboratory, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (C-BX); and Department of Thyroid and Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China (Z-HL).
authors.forename: Jiang-Rong
authors.initials: JR
authors.lastname: Luo
authors.forename: Chun-Bao
authors.initials: CB
authors.lastname: Xie
authors.forename: Zhi-Hui
authors.initials: ZH
authors.lastname: Li
mesh_terms: D000328:Adult; D000368:Aged; D002681:China; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000208:ethnology / Q000473:pathology / Q000628:therapy*; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D013330:Struma Ovarii / Q000208:ethnology / Q000473:pathology / Q000628:therapy*; D013964:Thyroid Neoplasms / Q000208:ethnology / Q000473:pathology / Q000628:therapy*; D013965:Thyroidectomy
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals